Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
about
Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo ClinicAssessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA.Costs of novel symptom management interventions and their impact on hospitalizations.Methodological issues in trials of complementary and alternative medicine interventions.A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program ResearMometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adultsPatient-reported outcome measures in inflammatory bowel disease.Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1Polarity Therapy for cancer-related fatigue in patients with breast cancer receiving radiation therapy: a randomized controlled pilot study.Quality of life and symptom burden among long-term lung cancer survivorsThe use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancerThe value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors.Genetic variations and patient-reported quality of life among patients with lung cancerRelationship between deficits in overall quality of life and non-small-cell lung cancer survivalConcordance between patient reports of cancer-related symptoms and medical records documentationComparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients.Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial.Metrics to assess quality of life after management of early-stage lung cancer.Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship.The peabody picture vocabulary test as a pre-screening tool for global cognitive functioning in childhood brain tumor survivors.Using patient-reported outcome measures for improved decision-making in patients with gastrointestinal cancer - the last clinical frontier in surgical oncology?Managing symptoms among patients with breast cancer during chemotherapy: results of a two-arm behavioral trial.Developing a valid patient-reported outcome measureAssessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1Statistical considerations in the psychometric validation of outcome measuresChemotherapy-induced peripheral neuropathy: prevention and treatment.Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature.The psychometric properties of cancer multisymptom assessment instruments: a clinical review.Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992).Xerostomia health-related quality of life: NRG oncology RTOG 0537.Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.Ultra-short PROMs: clever or not?Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice.Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study.
P2860
Q26860732-23A7C1BB-B0AC-4F96-B697-51C900AF96E1Q33601615-0386955E-9397-47D9-BABC-ADE5049C51BAQ33808701-121D7709-D645-439F-8580-06FB0BEDA02CQ33892540-8CA68B2C-AF85-4B1F-B5E6-D20E1BD431F1Q34139127-90BB1146-8D08-44B4-9385-A1EAF464FAD4Q34367737-6E361EAB-C9EF-48B1-8E64-1BFE3EE5BC26Q34417873-398EC1AD-0A2A-44C2-B3F2-7224340AB578Q34524596-CECBC318-F00D-43CD-A7F4-21D426C36EBFQ34679345-5F7A01E7-D6D6-4D68-A272-CF1C895E73CDQ34866427-927EAD4A-5F73-42F5-9C42-C2EC6713D8C1Q34893904-AC18D90A-D324-4530-B860-6545069F29F9Q35621522-E8172BAB-E7D7-4BA1-A4B1-123C16611C03Q35898610-51604CA2-89B7-4DE0-991A-3B888548D1D8Q35942617-E90109B1-4514-46E8-9A49-5746093BA41FQ36002272-18B6AD25-6B11-4E04-9C5C-94E3D2BD457BQ36055064-BB7C2AC2-A34D-4293-9ABF-BE99FBB1D3EDQ36055418-89715A3E-4383-4F71-9EF4-777744C58D7FQ36058264-CD138329-1960-4ED5-89A9-AD1FE0026776Q36058286-1841C776-586D-4C24-A8B9-6C3C200081CBQ36205212-9836D07E-1C3D-4A39-8BC8-C70003C05F86Q36219570-BF69673B-5639-446E-80AE-98B8D80CD4F8Q36350645-87043FD7-25AC-40F9-B203-CBB2A662912BQ36486055-A6CE2200-CAA4-4A59-8B43-2A8F77434CC1Q36851034-50A8F39A-FA8C-4DEA-9205-3579BDAE3B3DQ36926438-8D3B42BE-8DE7-4299-9239-3524E2D2D7C2Q36927798-6BDA4D1E-6BC1-4246-B7CD-7ED8F5072A75Q37103126-06C40BD2-9598-4B22-A3B5-8B935C51CB70Q37120835-54842DB4-9929-479A-9D45-6430937BA26DQ37161133-753E88C2-25AC-4528-A967-12BDA98623E6Q37219659-DF171C0E-77E5-4E67-AC72-47EBC4DA3297Q37911252-3FD5D2B6-EED4-44D8-8183-C76D5D8D7938Q37974971-3AF1F2C2-F0D2-4F83-9DD1-301FDBA3181EQ38430860-050CF4C5-2075-42D0-A28E-4564A1192423Q39640851-8AAE9885-0F40-42AF-84A6-88DEC5D5B303Q39969599-EA8B9E4D-6C52-4ED1-9014-C98D08D554B8Q40343246-4E6A0238-2381-44FC-A78F-719D16DBE628Q42346285-008B31D3-D659-4B5F-A2A6-E55D28AE9682Q47110733-16126AF1-0E0F-4085-8548-3B8C42A49FE4Q48443184-5AA71BA1-1D69-437C-BB52-C5E6C4C1C9B2Q50103900-A89C44C1-6611-4691-94F7-D05130665B95
P2860
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Integrating patient-reported o ...... ored clinical trials networks.
@en
type
label
Integrating patient-reported o ...... ored clinical trials networks.
@en
prefLabel
Integrating patient-reported o ...... ored clinical trials networks.
@en
P2093
P356
P1476
Integrating patient-reported o ...... ored clinical trials networks.
@en
P2093
Amylou C Dueck
Edward G Shaw
Gary R Morrow
Gwen Wyatt
Jeff A Sloan
Joseph Roscoe
Lawrence Berk
Michael J Fisch
P304
P356
10.1200/JCO.2007.12.7670
P407
P577
2007-11-01T00:00:00Z